|
Originally published In Press as doi:10.1074/jbc.M207358200 on July 29, 2002
J. Biol. Chem., Vol. 277, Issue 40, 36962-36969, October 4, 2002
Rac Activation upon Cell-Cell Contact Formation Is Dependent on
Signaling from the Epidermal Growth Factor Receptor*
Martha
Betson,
Encarnación
Lozano §,
Juankun
Zhang§, and
Vania M. M.
Braga§¶
From the Medical Research Council Laboratory for Molecular Cell
Biology and the Department of Biochemistry and Molecular Biology,
University College London, Gower Street,
London WC1E 6BT, United Kingdom
Received for publication, July 22, 2002
 |
ABSTRACT |
Cadherins are transmembrane receptors that
mediate cell-cell adhesion. They play an essential role in
embryonic development and maintenance of tissue architecture. The Rho
family small GTPases regulate actin cytoskeletal dynamics in different
cell types. The function of two family members, Rho and Rac, is
required for the stability of cadherins at cell-cell contacts.
Consistent with the published data we have found that Rac is activated
upon induction of intercellular adhesion in epithelial cells. This
activation is dependent on functional cadherins (Nakagawa, M., Fukata,
M., Yamaga, M., Itoh, N., and Kaibuchi, K. (2001) J. Cell
Sci. 114, 1829-1838; Noren, N. K., Niessen, C. M.,
Gumbiner, B. M., and Burridge, K. (2001) J. Biol.
Chem. 276, 3305-3308). Here we show for the first time that
clustering of cadherins using antibody-coated beads is sufficient to
promote Rac activation. In the presence of Latrunculin B, Rac can be
partially activated by antibody-clustered cadherins. These results
suggest that actin polymerization is not required for initial Rac
activation. Contrary to what has been described before,
phosphatidylinositol 3-kinases are not involved in Rac activation
following cell-cell adhesion in keratinocytes. Interestingly,
inhibition of epidermal growth factor receptor signaling efficiently
blocks the increased Rac-GTP levels observed after contact
formation. We conclude that cadherin-dependent
adhesion can activate Rac via epidermal growth factor receptor signaling.
 |
INTRODUCTION |
Cadherins are transmembrane receptors that mediate
calcium-dependent cell-cell adhesion. They play an
essential role in embryonic development and maintenance of tissue
architecture in adults (1). Cadherins interact in an anti-parallel
fashion with the same type of receptors on adjacent cells (known as
homophilic binding), thereby mediating formation of cell-cell contacts.
Intercellular adhesion is strengthened by the clustering of cadherin
receptors at junctions and the association between cadherin complexes
and the actin cytoskeleton (2, 3). Cadherin-dependent
adhesion is subject to regulation by cytoplasmic proteins, and recent
work has focused on modulation by the Rho family of small GTPases. Members of this family of GTP-binding proteins regulate actin cytoskeletal dynamics and focal complex formation in different cell
types (4). The function of two family members, Rho and Rac, is required
for the stability of cadherins at cell-cell contacts (5). The exact
mechanisms by which Rho and Rac operate are unclear, but we and others
have shown that Rac plays a role in actin recruitment to junctions (6)
and to clustered cadherin receptors (7, 8).
Rho and Rac function in signal transduction cascades downstream of a
variety of cell surface receptors. For example, Rho mediates stress
fiber formation in response to lysophosphatidic acid
(LPA)1 stimulation, whereas
Rac is required for growth factor-induced membrane ruffling (9). More
recently it has been directly demonstrated that ligand binding to cell
surface receptors can activate Rho and Rac (10, 11). In addition, the
regulation of the activity of Rho, Rac, and Cdc42 by integrin
engagement has been determined and shown to be dependent on time,
matrix composition, and matrix concentration (12-15).
Lately, it has become apparent that cadherin-mediated adhesion can
trigger intracellular signaling events including activation of
phosphatidylinositol 3-kinases (PI3-kinases) and the extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase pathway (16-18). In addition, the epidermal growth factor (EGF) receptor has been coimmunoprecipitated with the cadherin adhesion complex from epithelial cells and is activated upon cell-cell contact
formation (18, 19).
Furthermore, recent work has demonstrated that cell-cell contact
formation can activate Rac in Madine-Darby canine kidney and Chinese
hamster ovary cells transfected with C-cadherin (20, 21). Spreading of E-cadherin-expressing Chinese hamster ovary cells on immobilized E-cadherin ectodomain also induces Rac activation (22). In addition, levels of GTP-bound Rac are higher in
VE-cadherin-expressing endothelial cells than in
VE-cadherin-null cells (23). Although these studies showed that Rac
activation is dependent on cadherin function, they did not establish
the functional significance of Rac activation upon cell-cell contact
formation, nor did they address the question of whether cadherin
clustering is sufficient to enhance GTP loading on Rac. Although two
studies found that PI3-kinase activity was required for full Rac
activation, inhibition of PI3-kinase function did not reduce Rac
activity to basal levels (20, 22), suggesting that other signaling
pathways may be involved in Rac activation downstream of
cadherin-mediated adhesion.
In light of these results, we were interested to determine whether
cadherin-mediated adhesion could also activate Rac in keratinocytes. Normal keratinocytes provide the ideal system to look at Rac activation on induction of cell-cell adhesion. They can be grown to confluence in
the absence of cadherin-dependent contacts (in low calcium medium), and then cell-cell adhesion can be induced by addition of
calcium ions (known as the calcium switch) (24). Because cells are
confluent and touching each other, they do not need to migrate to form
junctions, and contact formation occurs rapidly. Using this system, we
investigated the requirements for Rac activation following cell-cell
contact formation in terms of (a) clustering of cadherin receptors, (b)
actin polymerization, and (c) PI3-kinase and EGF receptor signaling.
Our results shed light on the mechanisms via which cadherin receptors
are functionally coupled to Rac activation.
 |
EXPERIMENTAL PROCEDURES |
Cell Culture and Microinjection--
Normal human keratinocytes
(strains Kb and Sa, passages 3-7) were cultured as described
previously (25). Cells were grown to confluence in low calcium medium
(25). To induce intercellular adhesion calcium chloride was added to 2 mM. Microinjection experiments and recombinant protein
production were performed as described previously (7).
Antibodies and Immunofluorescence--
Immunofluorescence was
performed as described previously (7). Primary monoclonal antibodies
used were: anti-E-cadherin (HECD-1, mouse and ECCD-2, rat) (26);
anti-P-cadherin (NCC-CAD-299, mouse) (27);
anti- 3 1-integrin (VM-2, mouse) (28);
anti-Rac (23A8, mouse); anti-activated EGF receptor from Transduction
Laboratories (clone 74, mouse); and anti-diphosphorylated ERK1/2
from Sigma (mouse). Rabbit polyclonal antibodies used were:
anti- -catenin (VB1) (29); anti-phosphoSer473-Akt (PW66); anti-Akt
(PW56) (30); anti-phosphoTyr1173-EGF receptor (R42/pY1173) (31);
anti-EGF receptor (Cell Signaling Technology); and anti-ERK2
(Santa-Cruz). Secondary antibodies and Dextran-Texas Red were from
Jackson Immuno Research Laboratories (Stratech Scientific). Rabbit
anti-mouse IgG and fluorescein isothiocyanate-phalloidin were bought
from Sigma.
Pull-down Assays--
Pull-down assays, using a GST-PAK-CRIB
fusion protein, were performed essentially as described (32). One 9-cm
dish of confluent keratinocytes was used per data point. Cells were
lysed in lysis buffer (1% Triton X-100, 0.1% SDS, 0.5% sodium
deoxycholate, 50 mM Tris-HCl pH 7.5, 150 mM
sodium chloride, 10 mM magnesium chloride and 1 µg/ml
leupeptin, 1 µg/ml pepstatin, 0.1 mM phenylmethylsulfonyl fluoride, and 0.1 mM pefabloc). Lysates were incubated with
PAK-CRIB beads (20 µg/dish) for 45 min, and beads were washed three
times with wash buffer (1% Triton X-100, 50 mM Tris-HCl pH
7.5, 150 mM sodium chloride, and 10 mM
magnesium chloride). Precipitated proteins and 2% of each lysate were
separated by SDS-PAGE, blotted, and probed for Rac.
For antibody blocking experiments, cells were incubated with 5 µg/ml
HECD-1 and 2 µg/ml NCC-CAD-299 for 30 min at 37 °C prior to
addition of calcium. As a control, cells were preincubated with 7 µg/ml rabbit anti-mouse IgG. For clustering experiments, keratinocytes grown in low calcium medium were incubated for 15 min on
ice with 5 µg/ml HECD-1 and 2 µg/ml NCC-CAD-299. Anti-mouse IgG was
added to 35 µg/ml, and cells were incubated for 30 min at
37 °C.
For bead experiments, 15 µm latex beads (Polysciences) were coated
with HECD-1 described as previously (7). Latrunculin B (Calbiochem) was
titrated to 0.3 µM, which prevented actin cytoskeleton remodeling in keratinocytes without causing cellular retraction. Cells
were treated with Latrunculin B or Me2SO control for
10 min and incubated with HECD-1-coated beads (2.4 × 107 beads per dish) for 10 min before lysis. In
inhibition experiments, cells were incubated with 30 µM
LY294002 (Sigma), 316 nM tyrphostin AG1478 (Calbiochem)
(18), 35 µM PD98508 (Calbiochem), or Me2SO vehicle for 30 min prior to stimulation with 2 mM calcium
for 5 min. In EGF stimulation experiments, cells were incubated with LY294002 or Me2SO vehicle as described above before
stimulation with 10 nM EGF for 10 min.
Akt Phosphorylation--
To probe for Akt phosphorylation, cells
were lysed in lysis buffer (1% Triton X-100, 20 mM
-glycerophosphate, 20 mM sodium fluoride, 2 mM EDTA, 0.2 mM sodium vanadate, 10 mM benzamidine, 2.5 µg/ml microcystin, 1 µg/ml
leupeptin, 1 µg/ml pepstatin, 0.1 mM phenylmethylsulfonyl
fluoride, and 0.1 mM pefabloc). Lysates were separated by
SDS-PAGE, blotted, and probed using antibodies specific for total Akt
(PW66) or Akt phosphorylated on serine 473 (PW56) (30).
EGF Receptor Phosphorylation--
Cells were lysed in lysis
buffer (1% Triton X-100, 50 mM Tris-HCl pH 7.5, 150 mM sodium chloride, 2 mM EDTA, 1 µg/ml
leupeptin, 1 µg/ml pepstatin, 0.1 mM phenylmethylsulfonyl
fluoride, 0.1 mM pefabloc, 20 mM
-glycerophosphate, 20 mM sodium fluoride, 0.2 mM sodium vanadate, and 1 mM sodium molybdate).
Lysates were run on SDS-PAGE gels, blotted, and probed for total EGF
receptor, activated EGF receptor (clone 74), or EGF receptor
phosphorylated on tyrosine 1173 (R42/pY1173) (31).
 |
RESULTS |
Activated Rac Rescues the Effect of Dominant Negative Rac on
Junctions--
A number of studies have shown that a dominant negative
version of Rac (N17Rac) inhibits the localization of cadherin receptors at sites of cell-cell contact (6, 7). Dominant negative mutants are
presumed to function by sequestering upstream activators for the small
GTPases, the guanine nucleotide exchange factors (GEFs) (reviewed in
Ref. 33). However, there appears to be more than 46 GEFs for Rho family
GTPases, many of which are rather promiscuous in exchange activity
(reviewed in Ref. 34). Therefore, it is possible that N17Rac blocks
cadherin-mediated adhesion by inhibition of a Rho GTPase other than Rac.
To determine whether Rac does indeed play a role in regulation of
cadherin localization at intercellular junctions, we investigated whether an activated version of Rac (L61Rac) can rescue the inhibitory effect of N17Rac on cell-cell contacts. Normal human keratinocytes cultured in the absence of intercellular contacts were injected with
recombinant dominant negative Rac protein, and cell-cell adhesion was
induced for 1 h. Cells were fixed and stained for E-cadherin (Fig.
1, A and B). As
reported previously (7), N17Rac inhibited localization of cadherin
receptors at boundaries between injected cells (Fig. 1, A
and B). Microinjection of L61Rac alone had no effect on
cadherin localization at junctions after incubation for 1 h (Fig.
1, C and D). Interestingly, co-injection of
L61Rac and N17Rac completely rescued the inhibitory effect of N17Rac on
cadherin-mediated adhesion (Fig. 1, E and F).
This effect is specific for L61Rac because L61Cdc42 cannot restore
junctional cadherin staining in N17Rac-injected
cells.2 Together these
results provide strong evidence that N17Rac blocks localization of
cadherin receptors at junctions by inhibiting Rac function. Thus, Rac
plays an important role in the regulation of cadherin-mediated
adhesion.

View larger version (126K):
[in this window]
[in a new window]
|
Fig. 1.
Rac activity is required for localization of
cadherin receptors at cell-cell contact sites. Normal human
keratinocytes cultured in the absence of intercellular junctions were
microinjected with the following recombinant proteins: dominant
negative Rac (A and B, N17Rac),
activated Rac (C and D; L61Rac), or a
mixture of dominant negative and activated Rac (E and
F; N17Rac/L61Rac). Then cell-cell
adhesion was induced for 1 h, and cells were fixed and stained for
E-cadherin (B, D, and F).
Microinjected cells were visualized by co-injection of Dextran-Texas
Red (A, C, and E).
|
|
Rac Is Activated upon Cell-Cell Contact Formation in
Keratinocytes--
Because Rac activity is required for the stability
of cadherin receptors at junctions, is Rac activated upon cell-cell
contact formation in keratinocytes? To evaluate Rac activation, we
performed pull-down assays utilizing the Cdc42/Rac interactive binding
(CRIB) domain of the Rac effector p21-activated kinase (PAK) (32). We
confirmed the specificity of the assay under our conditions by loading
keratinocyte lysates with GTP S or GDP and assessing Rac activity
(Fig. 2a).

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 2.
Rac is activated upon induction of
cadherin-mediated adhesion in keratinocytes. a,
GST-PAK-CRIB specifically pulls down GTP-loaded Rac. Lysates from
confluent dishes of keratinocytes grown in the absence of cell-cell
adhesion were loaded with GTP S or GDP. GTP-Rac was pulled down with
GST-PAK-CRIB and detected by SDS-PAGE, Western blotting, and probing
for Rac. Samples of lysates were also fractionated to determine total
Rac levels. b and c, confluent dishes of
keratinocytes grown in the absence of intercellular contacts were
stimulated with 2 mM calcium for various time periods
(b, 0-20 min; c, 0-120 min), and the levels of
GTP-Rac and total Rac were determined as described above. d
and e, Rac activation is dependent on cadherin receptors.
d, keratinocytes were incubated with a mixture of anti-E-
and anti-P-cadherin antibodies or anti-mouse IgG for 30 min at
37 °C. Cells were treated with calcium for 30 min before fixing and
staining for E-cadherin. Bar, 50 µM.
e, keratinocytes were incubated as described in d
and treated with (+) or without ( ) calcium for 30 min before lysing
to assay for Rac activation. Results are representative of three
experiments.
|
|
To investigate whether cell-cell adhesion can activate the small GTPase
Rac, we grew keratinocytes in low calcium medium and induced cell-cell
contacts for various time periods before measuring Rac
activation. We found that endogenous Rac was activated 2-4-fold within
5 min of addition of calcium, and this activation was sustained up to
120 min (Fig. 2, b and c).
Rac Activation Is Dependent on Functional Cadherin
Receptors--
It is possible that the up-regulation of Rac described
above was caused by stimulation of calcium-dependent
intracellular signaling pathways rather than induction of
cadherin-dependent adhesion. To distinguish between these
two possibilities, we inhibited cadherin function during the calcium
switch. Keratinocytes express at least two members of the cadherin
family (E- and P-cadherin) (26). Cells were preincubated with anti-E-
and anti-P-cadherin antibodies at concentrations known to block
cadherin function in keratinocytes (24). To confirm that the antibodies
blocked cadherin function, we demonstrated that, in the presence of the inhibitory antibodies, no cadherin clustering was found at
intercellular boundaries (Fig. 2d). Incubation with
anti-cadherin antibodies prevented Rac up-regulation upon addition of
calcium ions, whereas control IgG did not (Fig. 2e). Thus,
the Rac activation is dependent on functional cadherin receptors, and
addition of calcium ions per se is not sufficient to trigger
Rac activation.
Clustering of Cadherins Activates Rac--
These results
demonstrated that cell-cell adhesion mediated by cadherins could
activate Rac in keratinocytes. Because junction formation is
accompanied by the clustering of cadherin receptors (3), we
investigated whether clustering of cadherins with antibodies was
sufficient to activate Rac. Keratinocytes grown in low calcium medium
were incubated with anti-E- and anti-P-cadherin antibodies (mouse
monoclonals). Clustering of the receptors was then induced by addition
of anti-mouse IgG, before assaying for Rac activity. Under these
conditions, we could observe clusters of cadherins on the cell surface
by immunofluorescence (Fig.
3A). We found that clustering
induced a modest increase in Rac activity relative to samples where the
anti-cadherin antibodies were omitted (Fig. 3B).
Quantification of the relative Rac activation in several experiments
revealed that treatment of cells with anti-cadherin antibodies alone
only induced a 1.2-fold increase in Rac activation relative to cells
treated with anti-mouse IgG alone. Clustering of surface cadherins with
two layers of antibodies induced a larger increase in Rac activation
(1.7-fold; Fig. 3, B and F).

View larger version (61K):
[in this window]
[in a new window]
|
Fig. 3.
Clustering of cadherin receptors induces Rac
activation. A, cadherins were clustered with a mixture
of mouse anti-E- and anti-P-cadherin antibodies and rabbit anti-mouse
IgG. Cells were fixed and stained with fluorescein
isothiocyanate-anti-rabbit secondary antibody. Bar, 32 µM. B, cells in low calcium were incubated
with (+) or without ( ) a mixture of anti-E- and anti-P-cadherin
antibodies for 15 min on ice. The antibodies were clustered with
anti-mouse IgG (+) or left untreated ( ) for 30 min at 37 °C, and
Rac activity was measured. Results are representative of seven
experiments. C, keratinocytes were incubated with beads
coated with anti-E-cadherin antibodies,
anti- 3 1-integrin antibodies, or BSA.
Coated beads were added, and cells were incubated for an additional 10 min. Cells were then fixed and stained for -catenin and F-actin. In
some experiments, keratinocytes were treated with Latrunculin B or
Me2SO vehicle for 10 min at 37 °C, prior to incubation
with beads. Arrows indicate beads that do not recruit
F-actin; arrowheads indicate beads that do recruit F-actin
and -catenin. Asterisks show beads with actin recruitment
but no -catenin staining. Bar, 18.6 µm. D,
cells were treated as in C, but after incubation with the
beads cells were lysed and Rac activation was assessed. Results are
representative of three experiments. E, cells were incubated
with anti- 3 1-integrin beads or BSA beads
for 10 min and lysed, and Rac activation was assessed. Results are
representative of two experiments. F and G,
quantification of antibody clustering and bead experiments. Activated
Rac levels were calculated as a percentage of total Rac levels in the
lysates. Rac activation is expressed relative to the controls; mouse
IgG alone (F) or Me2SO (DMSO) vehicle
with BSA beads (G), which were arbitrarily set as 1, are
shown.
|
|
However, the degree of Rac activation after antibody clustering is
lower than the activation observed following cell-cell contact
formation (2-4-fold). We hypothesized that this weak Rac activation
may be due to the small number of cadherin molecules per cluster
formed. To overcome this problem, we incubated cells for 10 min in low
calcium medium with beads coated with anti-E-cadherin antibodies.
Immunofluorescence of cells treated with these beads revealed binding
of anti-E-cadherin beads to the cell surface and recruitment of
-catenin and F-actin to the beads (Fig. 3C, arrowheads). In contrast, few beads coated with BSA alone
bound to the cell surface, and those that did recruited little
-catenin or F-actin (Fig. 3C, arrows,
top panels). We found that cells incubated with
anti-E-cadherin beads showed increased Rac activation in comparison
with cells treated with BSA beads (Fig. 3D). Quantification of the results of three experiments revealed that anti-E-cadherin beads
enhanced Rac activation by a factor of 2.1 compared with BSA beads
(Fig. 3G), suggesting that clustering of cadherins is sufficient to activate Rac.
To determine whether new actin polymerization is required for Rac
activation by clustered cadherin molecules, we treated cells with
Latrunculin B prior to receptor clustering. Latrunculin B inhibits
actin polymerization by sequestering actin monomers (36, 37). Treatment
of cells with Latrunculin B for 10 min before adding anti-E-cadherin
beads still allowed binding of beads to the cell surface and
recruitment of -catenin but blocked actin recruitment (Fig.
3C, arrows, bottom panels). Upon
assaying for Rac activation, we found that Latrunculin B treatment
per se caused an increase in Rac activation. Incubation with
E-cadherin beads in the presence of Latrunculin B induced a further
1.4-fold increase in Rac activation (Fig. 3, D and
G). Thus, Rac activation can occur in the absence of
de novo actin polymerization, but full induction of Rac
activity does require formation of new actin filaments.
However, the use of beads to artificially cluster cadherin receptors
may resemble the phagocytotic process. Rac activity is necessary for
Fc -mediated phagocytosis (38). Therefore, the possibility exists
that anti-E-cadherin beads may induce Rac activation by triggering
early events in phagocytosis. As a control to confirm that this was not
the case, we treated cells with beads coated with antibodies against
another cell surface receptor,
3 1-integrin. As expected, these beads
showed little staining for -catenin but did recruit F-actin (Fig.
3C, asterisks). However,
anti- 3 1-integrin beads did not induce
increased Rac activity relative to BSA control beads (Fig.
3E). Thus, the clustering of cadherin receptors can specifically activate Rac.
Rac Activation Is Dependent on EGF Receptor Signaling but Not
PI3-kinases--
We next explored which signaling pathways operate
downstream of cadherin-dependent contact formation to
induce Rac activity. We investigated three different classes of
signaling molecule: PI3-kinases, the EGF receptor, and ERK1/2.
We made use of the compounds LY294002, tyrphostin AG1478, and PD98059,
specific inhibitors of PI3-kinases, the EGF receptor, and
mitogen-activated kinase or ERK kinase-1 (MEK1), respectively (39-41).
We confirmed that the inhibitors were functional under our experimental
conditions by probing lysates for Akt phosphorylated on serine 473 (for
LY294002; Fig. 4A) or
activated ERK1/2 (AG1478 and PD98059; Fig. 4, B and
C). As expected, phosphorylation and activation of these
molecules were blocked.

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 4.
Rac activation is dependent on EGF receptor
signaling but not on PI3-kinase activity. Treatments with drugs to
inhibit PI3-kinase (A and D,
LY294002), EGF receptor (B and D,
AG1478), and MEK1 activation (C and E,
PD98059) were as follows. Cells in low calcium medium were
treated for 30 min with each inhibitor (+) or Me2SO vehicle
( ) and incubated in the presence (+) or absence of calcium ( ) for 5 min before lysis. Lysates were probed for phosphorylated Akt and total
Akt (A) or diphosphorylated ERK1/2 and total ERK-2
(B and C). Rac activation was also evaluated
following inhibition of PI3-kinase (D, LY294002),
EGF receptor (D, AG1478), or MEK1 activation
(E, PD98059). F, EGF-stimulated Rac
activation is dependent on PI3-kinase. Cells in low calcium medium were
incubated with LY294002 (+) or Me2SO vehicle ( ) as
described above and were stimulated for 10 min with EGF (+) or left
unstimulated ( ). Rac activation was then analyzed. G-I,
quantification of Rac activation in experiments inhibiting PI3-kinase
(LY294002), EGF receptor (AG1478), or MEK1
(PD98059). Activated Rac levels were calculated as a
percentage of total Rac levels in the lysates and normalized in two
different ways. G and H, Rac activation is
expressed relative to the Me2SO control (DMSO)
without calcium stimulation, which was arbitrarily set as 1. Note the
up-regulation of Rac-GTP levels by drug treatment (LY294002
and AG1478) in the absence of cell-cell adhesion. Results
represent mean ± S.E. of four experiments (LY294002 and AG1478
treatment) or two experiments (PD98059 treatment). I,
activated Rac levels are expressed relative to the low calcium control
treated with each drug, which was arbitrarily set as 1. The same set of
values used in G and H was recalculated to show
the changes in the levels of Rac-GTP following addition of calcium
ions. An increase in Rac activation levels is observed after cell-cell
adhesion in samples treated with LY294002 and PD98059 but not with
AG1478.
|
|
Inhibition of keratinocytes with LY294002 increased Rac activity
(compare with low calcium sample; Fig. 4D) but did not
inhibit Rac activation induced by cell-cell adhesion. We therefore
concluded that PI3-kinases do not play a major role in Rac activation
downstream of cadherin adhesion in keratinocytes.
Similarly to LY294002, treatment of keratinocytes with tyrphostin
AG1478 increased Rac activity (Fig. 4D). However, the drug dramatically decreased Rac activation upon induction of cell-cell adhesion. Therefore we concluded that EGF receptor function
participates in cadherin-dependent Rac stimulation (Fig.
4D). Consistent with this conclusion, calcium-induced
cell-cell adhesion induces EGF receptor activation in normal
keratinocytes3 as has been
observed in HaCat cells (18).
Rac activation in these experiments was quantified relative to the
control low calcium cultures treated with Me2SO (Fig.
4G; calcium, DMSO). However, there
was some variability in the degree of Rac activation induced by drug
treatment per se. For this reason Rac activity was also
calculated relative to the control low calcium cultures treated with
each inhibitor and was arbitrarily set at 1 (Fig. 4I;
calcium).
The inhibitors Latrunculin B, AG1478, or LY294002 can all activate Rac
in keratinocytes. To investigate whether this Rac activation is a
nonspecific consequence of treatment with different inhibitors, we
incubated cells with the MEK1 inhibitor PD98059. Treatment with PD98059
compound did not increase the basal level of Rac activity in low
calcium medium, nor did it inhibit activation of Rac induced by
cell-cell contact formation (Fig. 4E). Quantification of
these experiments is shown in Fig. 4, H and I.
Thus, blocking signaling pathways in general does not lead to Rac
activation. In addition, these results suggested that the
ERK/mitogen-activated kinase cascade is not involved in induction of
GTP loading on Rac downstream of cadherin-dependent adhesion.
EGF-stimulated activation of Rac is PI3-kinase-dependent in
fibroblasts (42). Given our results, we were interested to determine whether a similar pathway exists in keratinocytes. Cells grown in the
absence of cell-cell contacts were incubated with the PI3-kinase inhibitor LY294002 and stimulated with EGF for 10 min. Whereas in
untreated cells EGF stimulation induces a strong Rac activation, this
is blocked by inhibition of PI3-kinase (Fig. 4F). Thus, as in fibroblasts, EGF-induced Rac activation is
PI3-kinase-dependent in keratinocytes.
 |
DISCUSSION |
Our results demonstrate for the first time that activated Rac can
rescue the inhibitory effect of a dominant negative Rac mutant on the
localization of cadherin receptors at cell-cell contact sites. This
effect is specific for activated Rac and cannot be mimicked by
activated Cdc42,2 thus providing strong evidence that Rac
plays a role in the regulation of intercellular junctions in
keratinocytes. Similarly, our previous work has shown that active Rac
cannot compensate for the loss of Rho function in cadherin-mediated
adhesion and epithelial morphology (7, 35). Taken together, our results
indicate that Rho, Rac, and Cdc42 have distinct functions during
junction formation in keratinocytes.
We have shown that induction of cell-cell adhesion in keratinocytes
specifically causes an up-regulation of Rac activity. This increased
Rac activation is blocked by inhibition of cadherin function,
consistent with published data (20, 21). Most importantly, here we have
demonstrated that clustering of cadherins using antibody-coated beads
per se is indeed sufficient to induce GTP loading on Rac. This response is specific to clustering of cadherins and is not achieved upon clustering of 3 1-integrins
in keratinocytes.
We have shown previously that Rac plays a role in actin recruitment to
clustered E-cadherin receptors (7). Now we demonstrate for the first
time that Rac activation can occur independently of de novo
actin polymerization. However, full induction of GTP loading on Rac
requires formation of new actin filaments. Approximately 50% of
cadherin receptors are associated with actin filaments in the absence
of cell-cell adhesion (43). Thus, clustering of this pool of receptors
would provide a framework for new actin polymerization.
Subsequent adhesion-dependent Rac activation further enhances actin recruitment and polymerization, thereby stabilizing cadherin receptors at junctions.
In the course of these experiments, we observed that treatment of
keratinocytes with two drugs that affect the actin cytoskeleton, Latrunculin B and cytochalasin D, induces Rac activation (Fig. 3D and data not shown). Both drugs inhibit actin
polymerization, but they do so by different mechanisms (36, 37, 44).
Interestingly, cytochalasin D treatment has also been shown to activate
Rho (10). In addition, drugs that affect the microtubule network have
been shown to influence Rho and Rac activity (10, 45). Thus, the activity of Rho family GTPases appears to be acutely sensitive to the
polymerization state of microfilaments and microtubules. It is
conceivable that regulatory proteins such as GEFs and GTPase activating
proteins (GAPs) localize at cytoskeletal filaments and that upon
disruption of the network they may be released/modified to up-regulate
Rho and Rac activity.4
Similarly to what is observed with disruption of actin filaments,
inhibition of PI3-kinases (LY294002) and the EGF receptor (AG1478)
increased the basal levels of Rac activation. This was not a general
consequence of treating cells with inhibitors of signaling molecules
because the PD98059 inhibitor, which blocks MEK1 activation, did not
enhance Rac activity. Although these results are surprising, the
mechanisms via which these drugs may interfere with activation of Rho
proteins are beyond the scope of this manuscript.
How can clustering of cadherin receptors promote Rac activation? To
address this question we investigated which signaling pathways might be
involved. In contrast to the work of Nakagawa et al. (20),
we have found that Rac activation following cell-cell contact formation
is not dependent on PI3-kinase activity. Our results are consistent
with another report in which initial Rac activation following adhesion
of E-cadherin-expressing Chinese hamster ovary cells to E-cadherin
ectodomain is PI3-kinase-independent (22). Another situation in which
Rac activation occurs independently of PI3-kinase activity is in
chemoattractant-stimulated neutrophils (46).
In contrast, we have demonstrated that EGF receptor signaling
participates in the stimulation of Rac activity in keratinocytes upon
junction formation. Inhibition of EGF receptor signaling blocks Rac
activation both initially (Fig. 4D) and at later time points
after induction of cell-cell adhesion.3 Consistent with
this, in normal keratinocytes cell-cell adhesion activates the EGF
receptor, and phosphorylated EGF receptor is recruited to cadherin
clustered by beads.3 Preliminary work suggests that EGF
receptor signaling is also required for increased GTP loading on Rac
induced by clustering of cadherin molecules on beads.3 Our
data are in agreement with the proposal that cadherin clustering leads
to EGF receptor recruitment and activation at cell-cell contact sites
(18, 19).
Similar to other cell systems (e.g. fibroblasts),
EGF-stimulated Rac activation is PI3-kinase-dependent in
keratinocytes. This suggests that EGF receptor-induced Rac activation
proceeds by two different mechanisms, depending on how the EGF receptor is activated (i.e. by clustering with cadherins or by ligand
binding). In support of this theory, there is some evidence in
the literature suggesting that the consequences of EGF receptor
activation may depend on both the ligand and the localization of the
receptor in the cell (apical or basolateral domains) (47-49).
Based on the fact that Rac function stabilizes cadherin receptors at
junctions (7) and our present results, we expected that the EGF
receptor inhibitor (AG1478) would interfere with establishment of
cell-cell contacts. To our surprise, the inhibition of EGF receptor
signaling does not block localization of cadherins at junctions upon
addition of calcium ions.3 Similar observations were made
in Madine-Darby canine kidney cells; although PI3-kinase inhibition
diminished Rac activation, it did not block junction formation or
recruitment of GFP-Rac to junctions (20).
One explanation for these observations is that because the pull-down
assay measures global Rac activation, it is possible that the results
do not reflect localized changes in Rac activity at cell-cell contacts.
Alternatively, EGF receptor inhibition may cause an increased rate of
GTP cycling on Rac, so no net increase in GTP-bound Rac is observed
(50).
Two further considerations should be taken into account here:
(a) Rac activity is required for the stabilization of
cell-cell contacts rather than cadherin clustering per
se5 and (b)
blocking Rac function only inhibits 50% of actin recruitment to
clustered cadherin receptors (7), suggesting that alternative pathways
also contribute to actin polymerization at junctions. One possibility
is Cdc42, which can promote actin accumulation at cell-cell contact
sites and is activated upon intercellular junction formation in MCF-7
cells (16, 51). Other GTPase-independent pathways may also be involved,
including calcium signaling and Ena/VASP (52, 53). These pathways may
compensate for the reduction in Rac activation caused by EGF receptor
inhibition. Nevertheless, basal levels of activated Rac are still
necessary for stable cell-cell contacts because complete inhibition of
Rac activity destabilizes cadherin-mediated adhesion (Fig. 1) (7).
If EGF receptor-dependent Rac activation does not play a
role in cadherin stabilization at junctions, which other signaling events would Rac activation trigger? Our recent results suggest that
when EGF receptor signaling is inhibited, there is no delay in actin
recruitment to junctions or formation of other adhesive structures such
as desmosomes.3 We speculate that the EGF
receptor-dependent Rac activation may play a role in other
cadherin-dependent cellular processes, e.g. regulation of growth and/or differentiation of epithelia. Clearly more
experiments are required to resolve this issue.
The link between EGF receptor activation and the increase in GTP
loading in Rac is unclear presently. It is likely to involve activation
of a Rac-GEF (promoting GTP loading on Rac) or inhibition of a Rac-GAP
(thereby preventing GTP hydrolysis). Both mechanisms would result in an
increase in the levels of Rac-GTP. Work is in progress to identify the
GEFs or GAPs responsible for Rac activation during junction formation
in keratinocytes.
Evidence is accumulating for the existence of a cross-talk between
cadherin-mediated adhesion and growth factor signaling. For example,
non-adhesive cadherin receptors associate with insulin receptor
substrate 1 (54), whereas VE-cadherin interacts with VEGFR-2 in
endothelial cells (55). The communication between cadherins and growth
factor receptors may be analogous to the cross-talk observed between
integrins and growth factor receptors, which regulates cell survival
and proliferation (56). This cross-talk may also contribute to the
differences in cadherin signaling in different cells types, depending
on the growth factor receptor that is able to associate with the
cadherin complexes.
Here we demonstrate in epithelia the first example of cross-talk
between cadherins, growth factors, and small GTPases. In keratinocytes,
cadherin receptor clustering is sufficient to activate Rac, and
cadherin-dependent Rac activation requires EGF receptor signaling. The functional implications of the EGF
receptor-dependent Rac activation are unclear at the
moment. Potential roles include the regulation of cellular
morphogenesis, epithelial differentiation, and growth, events in which
cadherin adhesion, Rac, and EGF receptor signaling have been implicated
(1, 5, 57). Further work is needed to determine which of these
processes are modulated by the cross-talk between cadherin receptors
and signaling molecules.
 |
ACKNOWLEDGEMENTS |
We thank L. Cramer and C. Gauthier-Rouviere
for helpful discussions. We also thank M. Takeichi, D. Kwiatkowski, S. Hirohashi, J. Downward, and H. Huitfeldt for antibodies; J. Collard for
the GST-PAK-CRIB construct; and A. Hall, S. Etienne-Manneville, and J. Connolly for reagents.
 |
FOOTNOTES |
*
This work was supported by the Cancer Research Campaign and
the Medical Research Council (Senior Research Fellowship to V. B.;
Postdoctoral Fellowship to J. K. Z.; Ph.D. studentship to M. B.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by a fellowship from the Ministerio de Ciencia y
Tecnología, Spain.
§
Present address: Cell and Molecular Biology Section, Division of
Biomedical Sciences, Faculty of Medicine, Imperial College, Sir
Alexander Fleming Bldg., Exhibition Rd., London SW7 2AZ, United Kingdom.
¶
To whom correspondence should be addressed. Tel.:
44-20-7594-3233; Fax: 44-20-7594-3015; E-mail: v.braga@ic.ac.uk.
Published, JBC Papers in Press, July 29, 2002, DOI 10.1074/jbc.M207358200
2
J. K. Zhang, unpublished observations.
3
M. Betson, E. Lozano, and V. M. M. Braga,
unpublished observations.
4
Braga, V. M. M. (2002) Curr. Opin. Cell
Biol., in press.
5
V. M. M. Braga, unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
LPA, lysophosphatidic acid;
ERK, extracellular signal-regulated kinase;
EGF, epidermal growth factor;
PI3-kinase, phosphatidylinositol
3-kinase;
GEF, guanine nucleotide exchange factor;
CRIB, Ccd42/Rac
interactive binding;
PAK, p21-activated kinase;
GAP, GTPase activating
protein;
MEK, mitogen-activated protein kinase/ERK kinase;
BSA, bovine
serum albumin;
VE, vascular endothelial.
 |
REFERENCES |
| 1.
|
Gumbiner, B. M.
(1996)
Cell
84,
345-357[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Adams, C. L.,
and Nelson, W. J.
(1998)
Curr. Opin. Cell Biol.
10,
572-577[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Yap, A. S.,
Brieher, W. M.,
and Gumbiner, B. M.
(1997)
Ann. Rev. Cell Dev. Biol.
13,
119-146[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Hall, A.
(1998)
Science
279,
509-514[Abstract/Free Full Text]
|
| 5.
|
Braga, V.
(2000)
Exp. Cell Res.
261,
83-90[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Takaishi, K.,
Sasaki, T.,
Kotani, H.,
Nishioka, H.,
and Takai, Y.
(1997)
J. Cell Biol.
139,
1047-1059[Abstract/Free Full Text]
|
| 7.
|
Braga, V. M. M.,
Machesky, L. M.,
Hall, A.,
and Hotchin, N. A.
(1997)
J. Cell Biol.
137,
1421-1431[Abstract/Free Full Text]
|
| 8.
|
Lambert, M.,
Choquet, D.,
and Mege, R.-M.
(2002)
J. Cell Biol.
157,
469-479[Abstract/Free Full Text]
|
| 9.
|
Kjoller, L.,
and Hall, A.
(1999)
Exp. Cell Res.
253,
166-179[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Ren, X. D.,
Kiosses, W. B.,
and Schwartz, M. A.
(1999)
EMBO J.
18,
578-585[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Bernard, V.,
Bohl, B.,
and Bokoch, G.
(1999)
J. Biol. Chem.
274,
13196-13204
|
| 12.
|
Adams, J. C.,
and Schwartz, M. A.
(2000)
J. Cell Biol.
150,
807-822[Abstract/Free Full Text]
|
| 13.
|
del Pozo, M. A.,
Price, L. S.,
Alderson, N. B.,
Ren, X. D.,
and Schwartz, M. A.
(2000)
EMBO J.
19,
2008-2014[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Cox, E. A.,
Sastry, S. K.,
and Huttenlocher, A.
(2001)
Mol. Biol. Cell
12,
265-277[Abstract/Free Full Text]
|
| 15.
|
Wenk, M. B.,
Midwood, K. S.,
and Schwarzbauer, J. E.
(2000)
J. Cell Biol.
150,
913-919[Abstract/Free Full Text]
|
| 16.
|
Kim, S. H., Li, Z.,
and Sacks, D. B.
(2000)
J. Biol. Chem.
275,
36999-37005[Abstract/Free Full Text]
|
| 17.
|
Pece, S.,
Chiariello, M.,
Murga, C.,
and Gutkind, J. S.
(1999)
J. Biol. Chem.
274,
19347-19351[Abstract/Free Full Text]
|
| 18.
|
Pece, S.,
and Gutkind, J. S.
(2000)
J. Biol. Chem.
275,
41227-41233[Abstract/Free Full Text]
|
| 19.
|
Hoschuetzky, H.,
Aberle, H.,
and Kemler, R.
(1994)
J. Cell Biol.
127,
1375-1380[Abstract/Free Full Text]
|
| 20.
|
Nakagawa, M.,
Fukata, M.,
Yamaga, M.,
Itoh, N.,
and Kaibuchi, K.
(2001)
J. Cell Sci.
114,
1829-1838[Abstract]
|
| 21.
|
Noren, N. K.,
Niessen, C. M.,
Gumbiner, B. M.,
and Burridge, K.
(2001)
J. Biol. Chem.
276,
3305-3308
|
| 22.
|
Kovacs, E. M.,
Ali, R. G.,
McCormack, A. J.,
and Yap, A. S.
(2002)
J. Biol. Chem.
277,
6708-6718[Abstract/Free Full Text]
|
| 23.
|
Lampugnani, M. G.,
Zanetti, A.,
Breviario, F.,
Balconi, G.,
Orsenigo, F.,
Corada, M.,
Spagnuolo, R.,
Betson, M.,
Braga, V.,
and Dejana, E.
(2002)
Mol. Biol. Cell
13,
1174-1189
|
| 24.
|
Hodivala, K. J.,
and Watt, F. M.
(1994)
J. Cell Biol.
124,
589-600[Abstract/Free Full Text]
|
| 25.
|
Braga, V. M.,
Betson, M., Li, X.,
and Lamarche-Vane, N.
(2000)
Mol. Biol. Cell
11,
3703-3721[Abstract/Free Full Text]
|
| 26.
|
Hirai, Y.,
Nose, A.,
Kobayashi, S.,
and Takeichi, M.
(1989)
Development
105,
271-277[Abstract]
|
| 27.
|
Shimoyama, Y.,
Yoshida, T.,
Terada, M.,
Shimosato, Y.,
Abe, O.,
and Hirohashi, S.
(1989)
J. Cell Biol.
109,
1787-1794[Abstract/Free Full Text]
|
| 28.
|
Kaufmann, R.,
Frosch, D.,
Westphal, C.,
Weber, L.,
and Klein, C. E.
(1989)
J. Cell Biol.
109,
1807-1815[Abstract/Free Full Text]
|
| 29.
|
Braga, V. M. M.,
Hodivala, K. J.,
and Watt, F. M.
(1995)
Cell Adhes. Commun.
3,
201-215[Medline]
[Order article via Infotrieve]
|
| 30.
|
Watton, S. J.,
and Downward, J.
(1999)
Curr. Biol.
9,
433-436[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Oksvold, M. P.,
Skarpen, E.,
Lindeman, B.,
Roos, N.,
and Huitfeldt, H. S.
(2000)
J. Histochem. Cytochem.
48,
21-33[Abstract/Free Full Text]
|
| 32.
|
Sander, E. E.,
van Delft, S.,
Klooster, J. P.,
Reid, T.,
van der Kammen, R. A.,
Michaelis, F.,
and Collard, J. G.
(1998)
J. Cell Biol.
143,
1385-1398[Abstract/Free Full Text]
|
| 33.
|
Feig, L. A.
(1999)
Nat. Cell. Biol.
1,
E25-E27[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Zheng, Y.
(2002)
Trends Biochem. Sci.
26,
724-732
|
| 35.
|
Jou, T. S.,
and Nelson, W. J.
(1998)
J. Cell Biol.
142,
85-100[Abstract/Free Full Text]
|
| 36.
|
Coue, M.,
Brenner, S. L.,
Spector, I.,
and Korn, E. D.
(1987)
FEBS Lett.
213,
316-318[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Spector, I.,
Shochet, N. R.,
Blasberger, D.,
and Kashman, Y.
(1989)
Cell Motil. Cytoskeleton
13,
127-144[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Caron, E.,
and Hall, A.
(1998)
Science
282,
1717-1721[Abstract/Free Full Text]
|
| 39.
|
Vlahos, C. J.,
Matter, W. F.,
Hui, K. Y.,
and Brown, R. F.
(1994)
J. Biol. Chem.
269,
5241-5248[Abstract/Free Full Text]
|
| 40.
|
Levitzki, A.,
and Gazit, A.
(1995)
Science
267,
1782-1788[Abstract/Free Full Text]
|
| 41.
|
Alessi, D. R.,
Cuenda, A.,
Cohen, P.,
Dudley, D. T.,
and Saltiel, A. R.
(1995)
J. Biol. Chem.
270,
27489-27494[Abstract/Free Full Text]
|
| 42.
|
Ridley, A. J.,
Paterson, H. F.,
Johnston, C. L.,
Diekman, D.,
and Hall, A.
(1992)
Cell
70,
401-410[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Sako, Y.,
Nagafuchi, N.,
Tsukita, S.,
Takeichi, M.,
and Kusumi, A.
(1998)
J. Cell Biol.
140,
1227-1240[Abstract/Free Full Text]
|
| 44.
|
Sampath, P.,
and Pollard, T. D.
(1991)
Biochemistry
30,
1973-1980[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Waterman-Storer, C. M.,
Worthylake, R. A.,
Liu, B. P.,
Burridge, K.,
and Salmon, E. D.
(1999)
Nat. Cell. Bio.
1,
45-50[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Geijsen, N.,
van Delft, S.,
Raaijmakers, J. A. M.,
Lammers, J.-W. J.,
Collard, J. G.,
Koenderman, L.,
and Coffer, P. J.
(1999)
Blood
94,
1121-1130[Abstract/Free Full Text]
|
| 47.
|
Buse, P.,
Woo, P. L.,
Alexander, D. B.,
Reza, A.,
and Firestone, G. L.
(1995)
J. Biol. Chem.
270,
28223-28227[Abstract/Free Full Text]
|
| 48.
|
Cha, D.,
O'Brien, P.,
O'Toole, E. A.,
Woodley, D. T.,
and Hudson, L. G.
(1996)
J. Invest. Dermatol.
106,
590-597[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Amsler, K.,
and Kuwada, S. K.
(1999)
Am. J. Physiol.
276,
C91-C101[Medline]
[Order article via Infotrieve]
|
| 50.
|
Lin, R.,
Cerione, R. A.,
and Manor, D.
(1999)
J. Biol. Chem.
274,
23633-23641[Abstract/Free Full Text]
|
| 51.
|
Kodama, A.,
Takaishi, K.,
Nakano, K.,
Nishioka, H.,
and Takai, Y.
(1999)
Oncogene
18,
3996-4006[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Vasioukhin, V.,
Bauer, C.,
Yin, M.,
and Fuchs, E.
(2000)
Cell
100,
209-219[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Ko, K. S.,
Arora, P. D.,
Bhide, V.,
Chen, A.,
and McCulloch, C. A. G.
(2001)
J. Cell Sci.
114,
1155-1167[Abstract]
|
| 54.
|
Vasioukhin, V.,
Bauer, C.,
Degenstein, L.,
Wise, B.,
and Fuchs, E.
(2001)
Cell
104,
605-617[CrossRef][Medline]
[Order article via Infotrieve]
|
| 55.
|
Carmeliet, P.,
Lampugnani, M. G.,
Moons, L.,
Breviario, F.,
Compernolle, V.,
Bono, F.,
Balconi, G.,
Spagnuolo, R.,
Oostuyse, B.,
Dewerchin, M.,
Zanetti, A.,
Angellilo, A.,
Mattot, V.,
Nuyens, D.,
Lutgens, E.,
Clotman, F.,
de Ruiter, M. C.,
Gittenberger-de Groot, A.,
Poelmann, R.,
Lupu, F.,
Herbert, J. M.,
Collen, D.,
and Dejana, E.
(1999)
Cell
98,
147-157[CrossRef][Medline]
[Order article via Infotrieve]
|
| 56.
|
Giancotti, F. G.,
and Ruoslahti, E.
(1999)
Science
285,
1028-1032[Abstract/Free Full Text]
|
| 57.
|
Steinberg, M. S.,
and McNutt, P. M.
(1999)
Curr. Opin. Cell Biol.
11,
554-560[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Soto, M. Yanagisawa, L. A. Marlow, J. A. Copland, E. A. Perez, and P. Z. Anastasiadis
p120 catenin induces opposing effects on tumor cell growth depending on E-cadherin expression
J. Cell Biol.,
November 18, 2008;
183(4):
737 - 749.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Guillemot, S. Paschoud, L. Jond, A. Foglia, and S. Citi
Paracingulin Regulates the Activity of Rac1 and RhoA GTPases by Recruiting Tiam1 and GEF-H1 to Epithelial Junctions
Mol. Biol. Cell,
October 1, 2008;
19(10):
4442 - 4453.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Wheelock, Y. Shintani, M. Maeda, Y. Fukumoto, and K. R. Johnson
Cadherin switching
J. Cell Sci.,
March 15, 2008;
121(6):
727 - 735.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Perez, M. Tamada, M. P. Sheetz, and W. J. Nelson
Immediate-Early Signaling Induced by E-cadherin Engagement and Adhesion
J. Biol. Chem.,
February 22, 2008;
283(8):
5014 - 5022.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Yamada and W. J. Nelson
Localized zones of Rho and Rac activities drive initiation and expansion of epithelial cell cell adhesion
J. Cell Biol.,
July 24, 2007;
178(3):
517 - 527.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Tao, S. Nandadasa, P. D. McCrea, J. Heasman, and C. Wylie
G-protein-coupled signals control cortical actin assembly by controlling cadherin expression in the early Xenopus embryo
Development,
July 15, 2007;
134(14):
2651 - 2661.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Curto, B. K. Cole, D. Lallemand, C.-H. Liu, and A. I. McClatchey
Contact-dependent inhibition of EGFR signaling by Nf2/Merlin
J. Cell Biol.,
June 21, 2007;
177(5):
893 - 903.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Bruinsma, R. L. Cagan, and T. J. Baranski
Chimaerin and Rac regulate cell number, adherens junctions, and ERK MAP kinase signaling in the Drosophila eye
PNAS,
April 24, 2007;
104(17):
7098 - 7103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tscharntke, R. Pofahl, A. Chrostek-Grashoff, N. Smyth, C. Niessen, C. Niemann, B. Hartwig, V. Herzog, H. W. Klein, T. Krieg, et al.
Impaired epidermal wound healing in vivo upon inhibition or deletion of Rac1
J. Cell Sci.,
April 15, 2007;
120(8):
1480 - 1490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Yamazaki, T. Oikawa, and T. Takenawa
Rac-WAVE-mediated actin reorganization is required for organization and maintenance of cell-cell adhesion
J. Cell Sci.,
January 1, 2007;
120(1):
86 - 100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. F. Liu, C. M. Nelson, D. M. Pirone, and C. S. Chen
E-cadherin engagement stimulates proliferation via Rac1
J. Cell Biol.,
May 8, 2006;
173(3):
431 - 441.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sato, N. Fujita, A. Yamada, T. Ooshio, R. Okamoto, K. Irie, and Y. Takai
Regulation of the Assembly and Adhesion Activity of E-cadherin by Nectin and Afadin for the Formation of Adherens Junctions in Madin-Darby Canine Kidney Cells
J. Biol. Chem.,
February 24, 2006;
281(8):
5288 - 5299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. T. Chartier, M. Laine, S. Gout, G. Pawlak, C. A. Marie, P. Matos, M. R. Block, and M. R. Jacquier-Sarlin
Laminin-5-integrin interaction signals through PI 3-kinase and Rac1b to promote assembly of adherens junctions in HT-29 cells
J. Cell Sci.,
January 1, 2006;
119(1):
31 - 46.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zhang, M. Betson, J. Erasmus, K. Zeikos, M. Bailly, L. P. Cramer, and V. M. M. Braga
Actin at cell-cell junctions is composed of two dynamic and functional populations
J. Cell Sci.,
December 1, 2005;
118(23):
5549 - 5562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kim, A. J. Schein, and J. A. Nadel
E-cadherin promotes EGFR-mediated cell differentiation and MUC5AC mucin expression in cultured human airway epithelial cells
Am J Physiol Lung Cell Mol Physiol,
December 1, 2005;
289(6):
L1049 - L1060.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Andersen, J. Mejlvang, S. Mahmood, I. Gromova, P. Gromov, E. Lukanidin, M. Kriajevska, J. K. Mellon, and E. Tulchinsky
Immediate and Delayed Effects of E-Cadherin Inhibition on Gene Regulation and Cell Motility in Human Epidermoid Carcinoma Cells
Mol. Cell. Biol.,
October 15, 2005;
25(20):
9138 - 9150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kawakatsu, H. Ogita, T. Fukuhara, T. Fukuyama, Y. Minami, K. Shimizu, and Y. Takai
Vav2 as a Rac-GDP/GTP Exchange Factor Responsible for the Nectin-induced, c-Src- and Cdc42-mediated Activation of Rac
J. Biol. Chem.,
February 11, 2005;
280(6):
4940 - 4947.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fouquet, V.-H. Lugo-Martinez, A.-M. Faussat, F. Renaud, P. Cardot, J. Chambaz, M. Pincon-Raymond, and S. Thenet
Early Loss of E-cadherin from Cell-Cell Contacts Is Involved in the Onset of Anoikis in Enterocytes
J. Biol. Chem.,
October 8, 2004;
279(41):
43061 - 43069.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Johnson, C. S. Theisen, K. R. Johnson, and M. J. Wheelock
R-cadherin Influences Cell Motility via Rho Family GTPases
J. Biol. Chem.,
July 23, 2004;
279(30):
31041 - 31049.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Nelson, D. M. Pirone, J. L. Tan, and C. S. Chen
Vascular Endothelial-Cadherin Regulates Cytoskeletal Tension, Cell Spreading, and Focal Adhesions by Stimulating RhoA
Mol. Biol. Cell,
June 1, 2004;
15(6):
2943 - 2953.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Noritake, M. Fukata, K. Sato, M. Nakagawa, T. Watanabe, N. Izumi, S. Wang, Y. Fukata, and K. Kaibuchi
Positive Role of IQGAP1, an Effector of Rac1, in Actin-Meshwork Formation at Sites of Cell-Cell Contact
Mol. Biol. Cell,
March 1, 2004;
15(3):
1065 - 1076.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hoshino, K. Shimizu, T. Honda, T. Kawakatsu, T. Fukuyama, T. Nakamura, M. Matsuda, and Y. Takai
A Novel Role of Nectins in Inhibition of the E-Cadherin-induced Activation of Rac and Formation of Cell-Cell Adherens Junctions
Mol. Biol. Cell,
March 1, 2004;
15(3):
1077 - 1088.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-B. Guo, I. Lee, M. Kamar, and M. Pierce
N-Acetylglucosaminyltransferase V Expression Levels Regulate Cadherin-associated Homotypic Cell-Cell Adhesion and Intracellular Signaling Pathways
J. Biol. Chem.,
December 26, 2003;
278(52):
52412 - 52424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Fukuhara, K. Shimizu, T. Kawakatsu, T. Fukuhara, and Y. Takai
Involvement of Nectin-activated Cdc42 Small G Protein in Organization of Adherens and Tight Junctions in Madin-Darby Canine Kidney Cells
J. Biol. Chem.,
December 19, 2003;
278(51):
51885 - 51893.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Shimizu and Y. Takai
Roles of the Intercellular Adhesion Molecule Nectin in Intracellular Signaling
J. Biochem.,
November 1, 2003;
134(5):
631 - 636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Shigeta, N. Sanzen, M. Ozawa, J. Gu, H. Hasegawa, and K. Sekiguchi
CD151 regulates epithelial cell-cell adhesion through PKC- and Cdc42-dependent actin cytoskeletal reorganization
J. Cell Biol.,
October 13, 2003;
163(1):
165 - 176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S. Price, M. Langeslag, J. P. t. Klooster, P. L. Hordijk, K. Jalink, and J. G. Collard
Calcium Signaling Regulates Translocation and Activation of Rac
J. Biol. Chem.,
October 10, 2003;
278(41):
39413 - 39421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. K. Noren, W. T. Arthur, and K. Burridge
Cadherin Engagement Inhibits RhoA via p190RhoGAP
J. Biol. Chem.,
April 11, 2003;
278(16):
13615 - 13618.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kawakatsu, K. Shimizu, T. Honda, T. Fukuhara, T. Hoshino, and Y. Takai
trans-Interactions of Nectins Induce Formation of Filopodia and Lamellipodia through the Respective Activation of Cdc42 and Rac Small G Proteins
J. Biol. Chem.,
December 20, 2002;
277(52):
50749 - 50755.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|